![Nicholas Plummer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Plummer
Generell Rådgivare på
VOLITIONRX LIMITED
Förmögenhet: 54 369 $ per 2026-05-31
Profil
Nicholas Plummer is currently Group General Counsel at VolitionRX Ltd. since 2021.
Former roles include Secretary & General Counsel at Ark Therapeutics Group Plc from 2004 to 2008, Secretary & General Counsel at Novacyt SAS, Managing Counsel-Europe at Patheon France SAS from 2013 to 2021, and a position at Ashurst Morris Crisp from 2004 to 2007.
Education includes graduation from The University of Reading.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VOLITIONRX LTD 0,24 % | 2026-03-17 | 20 363 ( 0,24 % ) | 54 369 $ | 2026-05-31 |
Aktiva positioner av Nicholas Plummer
| Företag | Position | Start |
|---|---|---|
| VOLITIONRX LIMITED | Generell Rådgivare | 2021-11-01 |
Tidigare kända positioner av Nicholas Plummer
| Företag | Position | Slut |
|---|---|---|
Patheon France SAS
 Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2021-01-01 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Generell Rådgivare | 2008-01-01 |
| NOVACYT | Generell Rådgivare | - |
Nicholas Plummers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
